Treating iPSC-Derived β Cells with an Anti-CD30 Antibody–Drug Conjugate Eliminates the Risk of Teratoma Development upon Transplantation

por Pellegrini, Silvia, Zamarian, Valentina, Landi, Elisa, Cospito, Alessandro, Lombardo, Marta Tiffany, Manenti, Fabio, Citro, Antonio, Schiavo Lena, Marco, Piemonti, Lorenzo, Sordi, Valeria
Publicado 2022

PITX2 gain-of-function mutation associated with atrial fibrillation alters mitochondrial activity in human iPSC atrial-like cardiomyocytes

por Benzoni, Patrizia, Da Dalt, Lorenzo, Elia, Noemi, Popolizio, Vera, Cospito, Alessandro, Giannetti, Federica, Dell’Era, Patrizia, Olesen, Morten S., Bucchi, Annalisa, Baruscotti, Mirko, Norata, Giuseppe Danilo, Barbuti, Andrea
Publicado 2023

Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I(−/−) iPSCs for β cell replacement

por Chimienti, Raniero, Baccega, Tania, Torchio, Silvia, Manenti, Fabio, Pellegrini, Silvia, Cospito, Alessandro, Amabile, Angelo, Lombardo, Marta Tiffany, Monti, Paolo, Sordi, Valeria, Lombardo, Angelo, Malnati, Mauro, Piemonti, Lorenzo
Publicado 2022